Crestline Management, LP Axogen, Inc. Transaction History

Crestline Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	BUY	$15.23 - $21.72 $1.06 Million - $1.52 Million	69,777 New	69,777 $1.1 Million
Q4 2019 Feb 12, 2020	SELL	$11.18 - $18.6 $223,600 - $372,000	-20,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$12.09 - $20.46 $241,800 - $409,200	20,000 New	20,000 $250,000

179

36.2M

82.6K

1.1K

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $776M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

Stay updated on Crestline Management, LP with notifications on news.